Raleigh Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Raleigh Capital Management's OGN Position: Q1 2025 in Review
Raleigh Capital Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 231 shares — an estimated $3.45K sold.
Raleigh Capital Management first reported a position in OGN in Q4 2021 and held it in 12 quarters. The position peaked at $5.43K in Q1 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.
- Raleigh Capital Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
- Raleigh Capital Management sold 231 Organon & Co shares in Q1 2025, an estimated $3.45K.
- Raleigh Capital Management first reported a position in Organon & Co in Q4 2021 and held it in 12 quarters.
- Raleigh Capital Management's Organon & Co position peaked at $5.43K in Q1 2023.
- 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.
Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.